121 related articles for article (PubMed ID: 10545435)
1. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism.
Boffa JJ; Tharaux PL; Placier S; Ardaillou R; Dussaule JC; Chatziantoniou C
Circulation; 1999 Nov; 100(18):1901-8. PubMed ID: 10545435
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
Chatziantoniou C; Boffa JJ; Ardaillou R; Dussaule JC
J Clin Invest; 1998 Jun; 101(12):2780-9. PubMed ID: 9637712
[TBL] [Abstract][Full Text] [Related]
3. Regression of renal vascular fibrosis by endothelin receptor antagonism.
Boffa JJ; Tharaux PL; Dussaule JC; Chatziantoniou C
Hypertension; 2001 Feb; 37(2 Pt 2):490-6. PubMed ID: 11230324
[TBL] [Abstract][Full Text] [Related]
4. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta.
Fakhouri F; Placier S; Ardaillou R; Dussaule JC; Chatziantoniou C
J Am Soc Nephrol; 2001 Dec; 12(12):2701-2710. PubMed ID: 11729239
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms mediating the renal profibrotic actions of vasoactive peptides in transgenic mice.
Dussaule JC; Tharaux PL; Boffa JJ; Fakhouri F; Ardaillou R; Chatziantoniou C
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S124-8. PubMed ID: 11065343
[TBL] [Abstract][Full Text] [Related]
7. Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice.
Placier S; Boffa JJ; Dussaule JC; Chatziantoniou C
Nephrol Dial Transplant; 2006 Apr; 21(4):881-8. PubMed ID: 16384829
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway.
Tharaux PL; Chatziantoniou C; Fakhouri F; Dussaule JC
Hypertension; 2000 Sep; 36(3):330-6. PubMed ID: 10988260
[TBL] [Abstract][Full Text] [Related]
9. Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
François H; Placier S; Flamant M; Tharaux PL; Chansel D; Dussaule JC; Chatziantoniou C
FASEB J; 2004 May; 18(7):926-8. PubMed ID: 15033924
[TBL] [Abstract][Full Text] [Related]
10. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
11. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
D'Amours M; Lebel M; Grose JH; Larivière R
Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
[TBL] [Abstract][Full Text] [Related]
12. Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland.
Usui M; Ichiki T; Katoh M; Egashira K; Takeshita A
Hypertension; 1998 Sep; 32(3):527-33. PubMed ID: 9740621
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats.
Tharaux PL; Chatziantoniou C; Casellas D; Fouassier L; Ardaillou R; Dussaule JC
Circulation; 1999 Apr; 99(16):2185-91. PubMed ID: 10217661
[TBL] [Abstract][Full Text] [Related]
14. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
15. Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT.
Fortepiani LA; Ruiz MC; Passardi F; Bentley MD; Garcia-Estan J; Ritman EL; Romero JC
Am J Physiol Renal Physiol; 2003 Nov; 285(5):F852-60. PubMed ID: 12837684
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits.
Liu JL; Murakami H; Zucker IH
Circ Res; 1998 Mar; 82(4):496-502. PubMed ID: 9506710
[TBL] [Abstract][Full Text] [Related]
17. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
Helle F; Iversen BM; Chatziantoniou C
Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure.
Bautista R; Sánchez A; Hernández J; Oyekan A; Escalante B
Hypertension; 2001 Sep; 38(3 Pt 2):669-73. PubMed ID: 11566953
[TBL] [Abstract][Full Text] [Related]
19. [Vasoactive peptides and the development of renal sclerosis: contribution of transgenes].
Dussaule JC; Boffa JJ; Tharaux PL; Flamant M; Fakhouri F; Chatziantoniou C
J Soc Biol; 2002; 196(4):275-80. PubMed ID: 12645295
[TBL] [Abstract][Full Text] [Related]
20. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
